Description
The CB-CALLA monoclonal antibody specifically reacts with human CD10, a 100kDA type II glycoprotein also known as common acute lymphoblastic leukemia antigen (CALLA), enkephalinase, and neprilysin. CD10 is expressed on neutrophils and the precursors of B and T cells. It is involved in the neutrophil inflammatory and chemotactic responses and B cell development.